Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Target therapies in systemic lupus erythematosus: current state of the art.

Wiesik-Szewczyk E, Lacki JK, Feleszko W, Olesinska M.

Mini Rev Med Chem. 2010 Sep;10(10):956-65. Review.

PMID:
21034417
2.

B-cell-targeted therapy for systemic lupus erythematosus.

Sabahi R, Anolik JH.

Drugs. 2006;66(15):1933-48.

PMID:
17100405
3.

New treatments for SLE: cell-depleting and anti-cytokine therapies.

Anolik JH, Aringer M.

Best Pract Res Clin Rheumatol. 2005 Oct;19(5):859-78. Review.

PMID:
16150407
4.

Emerging biological therapies in systemic lupus erythematosus.

Mount GR, Gilliland WR.

Clin Pharmacol Ther. 2008 Jan;83(1):167-71. Epub 2007 Nov 14. Review.

PMID:
18000515
5.

B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.

Eisenberg R, Albert D.

Nat Clin Pract Rheumatol. 2006 Jan;2(1):20-7. Review.

PMID:
16932648
6.

B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab.

Wiesik-Szewczyk E, Olesinska M.

Biologics. 2012;6:347-54. doi: 10.2147/BTT.S25407. Epub 2012 Sep 26.

7.

B cells as therapeutic targets for rheumatic diseases.

Looney RJ, Anolik J, Sanz I.

Curr Opin Rheumatol. 2004 May;16(3):180-5. Review.

PMID:
15103242
8.

Monoclonal antibodies in the treatment of systemic lupus erythematosus.

Robak E, Robak T.

Curr Drug Targets. 2009 Jan;10(1):26-37. Review.

PMID:
19149533
9.

Biologics in the treatment of systemic lupus erythematosus.

Lateef A, Petri M.

Curr Opin Rheumatol. 2010 Sep;22(5):504-9. doi: 10.1097/BOR.0b013e32833b475e. Review.

PMID:
20502332
10.

Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.

Goldblatt F, Isenberg DA.

Handb Exp Pharmacol. 2008;(181):163-81. Review.

PMID:
18071946
11.

B-cell biology and related therapies in systemic lupus erythematosus.

Ahmed S, Anolik JH.

Rheum Dis Clin North Am. 2010 Feb;36(1):109-30, viii-ix. doi: 10.1016/j.rdc.2009.12.002.

PMID:
20202594
12.

[B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].

Tanaka Y.

Yakugaku Zasshi. 2009 Jun;129(6):675-9. Review. Japanese.

13.

[Interleukin 10 in disseminated lupus erythematosus].

Emilie D.

J Soc Biol. 2002;196(1):19-21. Review. French.

PMID:
12134628
14.

[Cytokine blockade - a promising therapeutic option in SLE].

Aringer M, Feierl E, Smolen J.

Z Rheumatol. 2008 Jul;67(4):315-7. doi: 10.1007/s00393-008-0303-8. Review. German.

PMID:
18491117
15.

Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab.

Tokunaga M, Fujii K, Saito K, Nakayamada S, Tsujimura S, Nawata M, Tanaka Y.

Rheumatology (Oxford). 2005 Feb;44(2):176-82. Epub 2004 Oct 19.

PMID:
15494350
16.

New immunosuppressive therapies in renal transplantation: monoclonal antibodies.

Buhaescu I, Segall L, Goldsmith D, Covic A.

J Nephrol. 2005 Sep-Oct;18(5):529-36. Review.

PMID:
16299678
17.

Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies.

Sousa E, Isenberg D.

Best Pract Res Clin Rheumatol. 2009 Aug;23(4):563-74. doi: 10.1016/j.berh.2008.12.006.

PMID:
19591785
18.

B-cell-directed therapies in systemic lupus erythematosus.

Tieng AT, Peeva E.

Semin Arthritis Rheum. 2008 Dec;38(3):218-27. doi: 10.1016/j.semarthrit.2007.11.003. Epub 2008 Feb 21. Review.

PMID:
18206214
19.

Treatment options for juvenile-onset systemic lupus erythematosus.

Carreño L, López-Longo FJ, González CM, Monteagudo I.

Paediatr Drugs. 2002;4(4):241-56. Review.

PMID:
11960513
20.

Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients.

Garcia-Carrasco M, Mendoza-Pinto C, Sandoval-Cruz M, Soto-Vega E, Beltran-Castillo A, Jimenez-Hernandez M, Graillet D, Gonzalez L, Rojas-Rodriguez J, Pineda-Almazana A, Zamudio-Huerta L, Lopez-Colombo A.

Lupus. 2010 Feb;19(2):213-9. doi: 10.1177/0961203309351541. Epub 2009 Dec 4.

PMID:
19965944

Supplemental Content

Support Center